900 related articles for article (PubMed ID: 17019404)
1. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
2. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
3. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats.
Ohata H; Suzuki K; Oki Y; Shibasaki T
Brain Res; 2000 Apr; 861(1):1-7. PubMed ID: 10751559
[TBL] [Abstract][Full Text] [Related]
4. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.
Fekete EM; Zhao Y; Szücs A; Sabino V; Cottone P; Rivier J; Vale WW; Koob GF; Zorrilla EP
Br J Pharmacol; 2011 Dec; 164(8):1959-75. PubMed ID: 21627635
[TBL] [Abstract][Full Text] [Related]
5. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient.
Currie PJ; Coscina DV; Bishop C; Coiro CD; Koob GF; Rivier J; Vale W
Brain Res; 2001 Oct; 916(1-2):222-8. PubMed ID: 11597609
[TBL] [Abstract][Full Text] [Related]
7. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake.
Chen X; Dong J; Jiang ZY
Regul Pept; 2012 Aug; 177(1-3):21-6. PubMed ID: 22561448
[TBL] [Abstract][Full Text] [Related]
8. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
Sajdyk TJ; Gehlert DR
Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
[TBL] [Abstract][Full Text] [Related]
9. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.
Cottone P; Sabino V; Nagy TR; Coscina DV; Zorrilla EP
J Physiol; 2007 Sep; 583(Pt 2):487-504. PubMed ID: 17627984
[TBL] [Abstract][Full Text] [Related]
10. Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus.
Wang C; Mullet MA; Glass MJ; Billington CJ; Levine AS; Kotz CM
Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R473-80. PubMed ID: 11208577
[TBL] [Abstract][Full Text] [Related]
11. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
[TBL] [Abstract][Full Text] [Related]
12. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.
Benoit SC; Thiele TE; Heinrichs SC; Rushing PA; Blake KA; Steeley RJ
Peptides; 2000 Mar; 21(3):345-51. PubMed ID: 10793215
[TBL] [Abstract][Full Text] [Related]
13. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
[TBL] [Abstract][Full Text] [Related]
14. Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus.
Wang C; Kotz CM
Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R358-67. PubMed ID: 12121849
[TBL] [Abstract][Full Text] [Related]
15. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
16. Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat.
Tanaka Y; Makino S; Noguchi T; Tamura K; Kaneda T; Hashimoto K
Neuroendocrinology; 2003 Jul; 78(1):1-11. PubMed ID: 12869794
[TBL] [Abstract][Full Text] [Related]
17. Long-term infusion of brain-derived neurotrophic factor reduces food intake and body weight via a corticotrophin-releasing hormone pathway in the paraventricular nucleus of the hypothalamus.
Toriya M; Maekawa F; Maejima Y; Onaka T; Fujiwara K; Nakagawa T; Nakata M; Yada T
J Neuroendocrinol; 2010 Sep; 22(9):987-95. PubMed ID: 20561155
[TBL] [Abstract][Full Text] [Related]
18. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
19. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.
Li C; Vaughan J; Sawchenko PE; Vale WW
J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127
[TBL] [Abstract][Full Text] [Related]
20. Corticotrophin-releasing factor mediates hypophagia after adrenalectomy, increasing meal-related satiety responses.
Uchoa ET; da Silva LE; de Castro M; Antunes-Rodrigues J; Elias LL
Horm Behav; 2010 Nov; 58(5):714-9. PubMed ID: 20688066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
